TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)
Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
TransMedics's pe ratio was 23.9× on Nov 11, 2026, against 59.2× a year earlier. Over the last 2 years it ranged from 15.2× to 98.5×, with a median of 58.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.9× | −25.4 |
| 2025 | Dec 31, 2025 | 49.3× | −17.1 |
| 2024 | Dec 31, 2024 | 66.3× | – |
See a number that looks wrong?